Babcock & Chemring: UK Mid-Cap Defense Profiles
Babcock International Group plc and Chemring Group plc are two separate, independently listed UK defense companies, grouped together here as representative mid-cap players in Britain's rearming defense sector. Babcock is a defense engineering and support group — naval maintenance, submarines, nuclear work and training. Chemring is a specialist in countermeasures and energetics, the flares, decoys, propellants and explosives that protect platforms and make munitions work. Both have benefited from the post-2022 defense upcycle, but they are very different businesses of very different sizes, as the figures below make clear.
Two Separate Companies
It is important to be clear at the outset: Babcock and Chemring are not related corporately. They are two distinct companies, each with its own London Stock Exchange listing, management and shareholders. They appear together on this page only because both are UK-listed, mid-cap defense businesses that illustrate the breadth of Britain's defense-industrial base beyond the largest prime, BAE Systems.
Babcock International Group plc trades under the ticker BAB and is the larger of the two — a broad engineering and support group. Chemring Group plc trades under CHG and is a smaller, more specialised supplier of countermeasures and energetic materials. One sells long-term services and engineering; the other sells defensive devices and the chemistry of munitions.
Reading them side by side is useful because together they show two routes by which the war in Ukraine has flowed into the UK defense sector: through demand to sustain and maintain forces (Babcock) and through demand to rebuild stocks of munitions and protective countermeasures (Chemring).
Market Capitalization & Revenue
| Company (ticker) | Market cap 2025–26 (approx.) | Revenue FY2025 (approx.) |
|---|---|---|
| Babcock International (LSE: BAB) | ~£5–6.5B (as of 2025-09 to 2026) | ~£4.8B |
| Chemring Group (LSE: CHG) | ~£1.4–1.8B (as of 2026-03) | ~£0.5B |
⚠ Figures are approximate and rounded. London-listed shares are quoted in pence (GBp); caps here are converted to pounds (£bn). Values are as-of snapshots that change daily (Babcock source and revenue source; Chemring source and FY2025 results source). Not investment advice.
The contrast in scale is stark. Babcock is several times larger than Chemring on both measures, reflecting its broad portfolio of multi-year naval and support contracts. Chemring is a focused specialist whose value rests on a narrower but strategically critical set of products. Neither has experienced the dramatic share-price re-rating seen at ammunition-heavy continental primes, but both have benefited from rising order books since 2022.
Babcock: Naval, Nuclear & Support
Babcock's business model is built on sustaining and supporting military capability rather than selling weapons outright. Its largest activities are in the naval domain: maintaining, refitting and supporting the Royal Navy's surface fleet and submarines, and running naval dockyards. This is long-cycle, recurring work backed by government contracts that can span many years.
The company is also deeply involved in submarine and nuclear-related programs, complex engineering that few firms can deliver and that sits at the heart of national security. Beyond the navy, Babcock provides training, equipment support, aviation and critical-asset services across the UK and selected international markets.
For investors, the appeal is visibility and resilience: through-life support contracts generate steady cash flow that is relatively insulated from the timing of one-off equipment orders. As NATO members maintain and expand their forces, demand for exactly this kind of sustainment engineering rises, supporting Babcock's order book and giving it durable, government-backed revenue.
Chemring: Countermeasures & Energetics
Chemring operates in two strategically critical niches. The first is countermeasures — the flares, chaff and decoys that protect aircraft, helicopters and ships from guided missiles. As air and missile threats proliferate, demand for these self-protection systems has grown across allied forces.
The second, and arguably more war-relevant, is energetics: the propellants, explosives, pyrotechnics and specialist components that make munitions function. This places Chemring inside the ammunition supply chain that the war in Ukraine has stretched to its limits. As Western governments race to rebuild artillery-shell and munitions capacity, the energetic materials Chemring supplies have become a bottleneck commodity, and the company has reported a record order book on the back of this demand.
Chemring also runs a sensors and information business focused on detection and electronic-warfare-adjacent technology. Though much smaller than Babcock, Chemring's exposure to munitions and protective countermeasures gives it one of the more direct links to the consumables of modern war among UK-listed defense names.
Relevance to the Ukraine War
The two companies connect to the war through different channels. Chemring's link is the more direct: its energetics feed the munitions supply chain, and the enormous artillery-ammunition consumption in Ukraine, combined with the drive to replenish depleted Western stockpiles, has lifted demand for propellants, explosives and components. Its countermeasures, meanwhile, address the intense missile and air threats the conflict has highlighted.
Babcock's relevance is broader and steadier. Higher defense budgets and the imperative to sustain larger, more active forces increase demand for the naval support, submarine work, maintenance and training that form its core. When militaries operate equipment harder and grow their fleets, the sustainment engineering Babcock provides becomes more valuable.
Neither company is a household name in Ukraine coverage the way ammunition primes are, but both sit firmly within the UK rearmament story. Together they show how the post-2022 defense upcycle reaches beyond headline weapons makers into the supporting industrial base of munitions, countermeasures and through-life support.
Key Data & Outlook
| Metric | Babcock International | Chemring Group |
|---|---|---|
| Ticker / exchange | BAB · LSE | CHG · LSE |
| Country | United Kingdom | United Kingdom |
| Focus | naval support, submarines, nuclear, training | countermeasures, energetics, sensors |
| Revenue FY2025 (approx.) | ~£4.8B | ~£0.5B |
| Market cap (approx.) | ~£5–6.5B | ~£1.4–1.8B |
| Ukraine relevance | sustainment, naval & submarine support, training as forces expand | energetics in the munitions supply chain; countermeasures vs missile threats |
⚠ Figures are approximate as-of snapshots. Outlooks depend on UK and NATO defense budgets, contract awards and execution; a slowdown in spending or stockpile replenishment could pressure either valuation. Not investment advice.
Frequently Asked Questions
Are Babcock and Chemring the same company?
No. Babcock International Group plc (LSE: BAB) and Chemring Group plc (LSE: CHG) are two entirely separate, independently listed UK defense companies. They are grouped together here only because both are UK-listed mid-cap defense businesses. Babcock is a defense engineering and support group; Chemring specialises in countermeasures and energetics.
What does Babcock International do?
Babcock is a defense engineering and support company. It maintains and supports warships and submarines for the Royal Navy, manages naval dockyards, works on nuclear and submarine programs, and provides training, equipment support and critical-asset services. Its model is built on long-term support contracts rather than selling weapons outright.
What does Chemring do?
Chemring makes countermeasures — flares and decoys that protect aircraft and ships from missiles — and energetic materials used in munitions, including propellants, explosives and components. It also has a sensors and information business. Its energetics work is directly relevant to the artillery-ammunition supply chains stressed by the war in Ukraine.
What are Babcock and Chemring worth?
In 2025-2026 Babcock's market capitalization was around £5 to £6.5 billion, while Chemring's was roughly £1.4 to £1.8 billion. Both are mid-cap UK defense stocks, far smaller than primes like BAE Systems. The figures are approximate as-of snapshots that change daily with the share price.
How much revenue do Babcock and Chemring make?
Babcock reported revenue of about £4.8 billion for its 2025 financial year, reflecting its large naval and support contracts. Chemring is much smaller, with revenue of roughly £0.5 billion in 2025, though it reported a record order book driven by demand for countermeasures and energetics.
Why is Chemring relevant to the Ukraine war?
Chemring's energetics business supplies propellants, explosives and components used in munitions, and the war has driven a surge in demand to rebuild artillery-ammunition capacity. Its countermeasures protect aircraft and ships from missile threats. Both lines benefit from the rearmament and stockpile-replenishment cycle the war triggered.
Why is Babcock relevant to the war?
Babcock benefits from higher defense spending through its naval support, submarine and training work, and from increased demand to sustain and upgrade military equipment. As NATO members rebuild and maintain larger forces, support engineering and through-life maintenance — Babcock's core business — become more valuable.
Is Babcock bigger than Chemring?
Yes. Babcock is several times larger than Chemring by both revenue and market capitalization. Babcock is a broad engineering and support group with multi-billion-pound revenue, while Chemring is a specialist in countermeasures and energetics with revenue around half a billion pounds.
Have these stocks risen because of the war?
Both have benefited from the post-2022 defense upcycle and rising order books, though neither saw the explosive re-rating of a company like Rheinmetall. Chemring's energetics exposure links it to ammunition demand, while Babcock's gains track higher naval and support spending. Valuations move with budgets and execution.
Where can I verify Babcock and Chemring figures?
Market-cap data are published by aggregators such as companiesmarketcap.com, stockanalysis.com and macrotrends.net, while revenue and order-book figures come from each company's own annual results. Always check the as-of date, since market caps change daily. This page is analysis, not investment advice.